[MYGN] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
08-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 8.15%
YoY- 27.95%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 204,060 202,467 174,116 156,472 149,140 133,437 132,965 32.94%
PBT 84,144 83,827 67,228 59,241 56,985 49,822 48,471 44.29%
Tax 33,784 28,362 23,153 21,349 21,949 19,686 19,330 44.94%
NP 50,360 55,465 44,075 37,892 35,036 30,136 29,141 43.86%
Tax Rate -40.15% -33.83% -34.44% -36.04% -38.52% -39.51% -39.88% -
Total Cost 153,700 147,002 130,041 118,580 114,104 103,301 103,824 29.79%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 24.68 27.39 25.31 24.22 23.49 22.58 21.92 8.20%
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS 0.67 0.70 0.55 0.47 0.43 0.37 0.35 53.98%
EPS Diluted 0.66 0.68 0.53 0.46 0.42 0.36 0.34 55.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.